spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  ferumoxytol 

 HSMN NewsFeed - 16 Jul 2021
Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 12 Oct 2016
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena(R) and Feraheme(R)
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2014
Lumara Health(TM) to be Acquired in Two Separate Transactions for up to $1.107 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Sep 2014
AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2014
AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2014
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2013
AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2013
AMAG Pharmaceuticals Appoints Carol Satler, M.D., Ph.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2010
AMAG Pharmaceuticals, Inc. Appoints Gary J. Zieziula as Executive Vice President and Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2010
AMAG Pharmaceuticals and Takeda Pharmaceutical Company Announce Strategic Collaboration for Feraheme(R) in All Therapeutic Indications in Select Ex-US Territories, Including Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Dec 2009
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2009
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2008
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2007
AMAG Pharmaceuticals, Inc. Announces Update on Sinerem(TM) in Europe
Biopharmaceuticals Radiology Regulatory
 HSMN NewsFeed - 6 Aug 2007
AMAG Pharmaceuticals, Inc. Announces Appointment of Lee F. Allen, M.D., Ph.D. as Chief Medical Officer and Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Advanced Magnetics, Inc. Announces Name Change to AMAG Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2007
Advanced Magnetics Announces Positive Results from Two Additional Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapeutic
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2007
Advanced Magnetics Announces Appointment of Kristen P. Galfetti as Senior Director Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2007
Advanced Magnetics Announces Appointment of David Arkowitz as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2007
Advanced Magnetics Completes Enrollment in Final Planned Phase III Study of Ferumoxytol as an IV Iron Replacement Therapeutic
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2007
Advanced Magnetics' Ferumoxytol Data Monitoring Committee Identifies No Safety Concerns in Final Data Review
Biopharmaceuticals
 HSMN NewsFeed - 15 Feb 2007
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation
Biopharmaceuticals Radiology Licensing Litigation
 HSMN NewsFeed - 4 Dec 2006
Advanced Magnetics, Inc. Announces Appointment of Timothy G. Healey as Senior Vice President of Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2006
Advanced Magnetics Announces Positive Results from Phase III Study of Ferumoxytol as an Intravenous Iron Replacement Therapeutic
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2006
Cancer Patients Show Reduced Pain and Lower Analgesic Consumption Following Treatment with QUADRAMET(R)
Biopharmaceuticals Onoclogy
 HSMN NewsFeed - 18 Sep 2006
Combination of High Dose QUADRAMET(R) and Chemotherapy Shows Promise for Treatment of High-Risk Acute Myeloid Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Sep 2006
Advanced Magnetics Announces the Appointments of Louis Brenner, MD as Senior Vice President and Mohammed A. Salem, PhD as Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2006
Advanced Magnetics Completes Enrollment in Two Phase III Studies of Ferumoxytol as an IV Iron Replacement Therapeutic
Biopharmaceuticals
 HSMN NewsFeed - 16 Aug 2006
Cytogen Launches SOLTAMOX(TM), First Oral Liquid Formulation of Hormonal Therapy for Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jul 2006
Cytogen Announces Initiation of Phase III Study Involving QUADRAMET(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Jul 2006
Cytogen Announces Publication of Peer-Reviewed Journal Article on QUADRAMET(R)
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2006
Cytogen Announces Departure of Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jun 2006
Cytogen and Philips Demonstrate PROSTASCINT(R) Image Acquisition and Processing Tools That Improve Efficiency and Reduce Imaging Time
Devices Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jun 2006
Data Presented at SNM Meeting Demonstrate New Potential for PROSTASCINT(R) through Advances in Nuclear Medicine Imaging
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jun 2006
Data Presented at SNM Meeting Demonstrate Novel Therapeutic Combinations and Applications for QUADRAMET(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 May 2006
New Study Demonstrates That Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Prostate Cancer Recurrence
Diagnostics Urology Oncology
 HSMN NewsFeed - 22 May 2006
Prostate-Specific Membrane Antigen (PSMA) Expression in Neovasculature Associated with Renal Cell Carcinoma is Characterized
Diagnostics Oncology Urology
 HSMN NewsFeed - 8 May 2006
Cytogen Announces FDA Clears IND for CYT-500, a Monoclonal Antibody for the Treatment of Metastatic Hormone-Refractory Prostate Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Apr 2006
Cytogen and Savient Finalize Exclusive Distribution Agreement for SOLTAMOX(TM)
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 24 Apr 2006
Advanced Magnetics Announces Appointment of Gerald L. Wolf, PhD, MD as Vice President of Imaging
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2006
Advanced Magnetics Announces Design of Phase III Iron Therapy Program for Ferumoxytol
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2006
Positive Findings from Clinical Studies of QUADRAMET(R) in Prostate Cancer Patients with Metastatic Bone Disease Presented at ASCO Prostate Cancer Symposium
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 21

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 21 additional stories matching:
ferumoxytol
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.